142 related articles for article (PubMed ID: 38354767)
1. Induction therapy for non-small cell lung cancer.
Cooper A; Chaft JE; Bott MJ
J Thorac Cardiovasc Surg; 2024 Feb; ():. PubMed ID: 38354767
[No Abstract] [Full Text] [Related]
2. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
[TBL] [Abstract][Full Text] [Related]
3. Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer.
van Meerbeeck JP; Kramer GW; Van Schil PE; Legrand C; Smit EF; Schramel F; Tjan-Heijnen VC; Biesma B; Debruyne C; van Zandwijk N; Splinter TA; Giaccone G;
J Natl Cancer Inst; 2007 Mar; 99(6):442-50. PubMed ID: 17374834
[TBL] [Abstract][Full Text] [Related]
4. Neoadjuvant Immunotherapy Combined with Chemotherapy for Local Advanced Non-Small-Cell Lung Cancer in a Patient with a History of Breast Cancer: A Case Report.
Yang RX; Hei Y; Zhu WT; Wang QR; Zhang HM; Chen Y
Curr Oncol; 2022 Aug; 29(9):6203-6210. PubMed ID: 36135056
[TBL] [Abstract][Full Text] [Related]
5. Short-course induction chemoradiotherapy with paclitaxel for stage III non-small-cell lung cancer.
Rice TW; Adelstein DJ; Ciezki JP; Becker ME; Rybicki LA; Farver CF; Larto MA; Blackstone EH
Ann Thorac Surg; 1998 Dec; 66(6):1909-14. PubMed ID: 9930467
[TBL] [Abstract][Full Text] [Related]
6. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung.
Schilder RJ; Goldberg M; Millenson MM; Movsas B; Rogatko A; Rogers B; Langer CJ
Lung Cancer; 2000 Jan; 27(1):37-45. PubMed ID: 10672782
[TBL] [Abstract][Full Text] [Related]
8. Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group.
Johnstone DW; Byhardt RW; Ettinger D; Scott CB
Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):365-9. PubMed ID: 12243809
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant immunotherapy combined with chemotherapy significantly improved patients' overall survival when compared with neoadjuvant chemotherapy in non-small cell lung cancer: A cohort study.
Dai F; Wu X; Wang X; Li K; Wang Y; Shen C; Zhou J; Niu H; Deng B; Tan Q; Wang R; Guo W
Front Oncol; 2022; 12():1022123. PubMed ID: 36353552
[TBL] [Abstract][Full Text] [Related]
10. Surgical strategies and outcomes after induction therapy for non-small cell lung cancer.
Burfeind WR; Harpole DH
Semin Thorac Cardiovasc Surg; 2005; 17(3):186-90. PubMed ID: 16253820
[TBL] [Abstract][Full Text] [Related]
11. Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.
Yang CF; Gulack BC; Gu L; Speicher PJ; Wang X; Harpole DH; Onaitis MW; D'Amico TA; Berry MF; Hartwig MG
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1484-92; discussion 1492-3. PubMed ID: 26259994
[TBL] [Abstract][Full Text] [Related]
12. Role of induction therapy: surgical resection of non-small cell lung cancer after induction therapy.
Ripley RT; Rusch VW
Thorac Surg Clin; 2013 Aug; 23(3):273-85. PubMed ID: 23931012
[TBL] [Abstract][Full Text] [Related]
13. Multimodality Therapy for N2 Non-Small Cell Lung Cancer: An Evolving Paradigm.
Spicer JD; Shewale JB; Nelson DB; Mitchell KG; Bott MJ; Vallières E; Wilshire CL; Vaporciyan AA; Swisher SG; Jones DR; Darling GE; Sepesi B
Ann Thorac Surg; 2019 Jan; 107(1):277-284. PubMed ID: 30227129
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy for early-stage non-small cell lung cancer: A system review.
Gao J; Zhang C; Wei Z; Ye X
J Cancer Res Ther; 2023 Aug; 19(4):849-865. PubMed ID: 37675709
[TBL] [Abstract][Full Text] [Related]
15. Short-term outcome of neoadjuvant immunotherapy and chemotherapy in non-small cell lung cancer: A systematic review and meta-analysis.
Zhang C; Hong HZ; Wu YL; Zhong WZ
JTCVS Open; 2021 Dec; 8():588-607. PubMed ID: 36004199
[TBL] [Abstract][Full Text] [Related]
16. Pre- and post- operative adjuvant targeting locoregional chemotherapy combined with locoregional targeting immunostimulation and surgical resection for hepatocellular carcinoma. A new promising alternative.
Lygidakis NJ; Konstantinidou T; Pothoulakis J
Anticancer Res; 1994; 14(3B):1351-5. PubMed ID: 8067704
[TBL] [Abstract][Full Text] [Related]
17. Non-small-cell lung cancer with pathological complete response after induction therapy followed by surgical resection: which is the pattern of failure and which are the future perspectives?
Lococo F; Chiappetta M; Cesario A; Margaritora S
Eur J Cardiothorac Surg; 2020 Aug; 58(2):407. PubMed ID: 32105333
[No Abstract] [Full Text] [Related]
18. Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial.
Rusch VW; Albain KS; Crowley JJ; Rice TW; Lonchyna V; McKenna R; Livingston RB; Griffin BR; Benfield JR
J Thorac Cardiovasc Surg; 1993 Jan; 105(1):97-104; discussion 104-6. PubMed ID: 8380477
[TBL] [Abstract][Full Text] [Related]
19. Mature results from a phase II trial of accelerated induction chemoradiotherapy and surgery for poor prognosis stage III non-small-cell lung cancer.
Adelstein DJ; Rice TW; Rybicki LA; Larto MA; Koka A; Taylor ME; Olencki TE; Peereboom DM; Budd GT
Am J Clin Oncol; 1999 Jun; 22(3):237-42. PubMed ID: 10362328
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant and adjuvant therapy for Stage III non-small cell lung cancer.
Watanabe SI; Nakagawa K; Suzuki K; Takamochi K; Ito H; Okami J; Aokage K; Saji H; Yoshioka H; Zenke Y; Aoki T; Tsutani Y; Okada M;
Jpn J Clin Oncol; 2017 Dec; 47(12):1112-1118. PubMed ID: 29136212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
